Solence raises €1.6M Seed funding to rethink PCOS care, aiming to provide personalised support for women with Polycystic Ovary Syndrome.

Jul 10, 2025•23 days ago

Amount Raised

€1.6 Million

Round Type

seed

ParisBiotechnologyHealth Care

Description

Women's health startup Solence has raised €1.6 million in Seed funding to help women suffering from Polycystic Ovary Syndrome (PCOS). The funding will enable the development of their digital therapeutics and patient-centric care solutions. Solence aims to provide tailored treatment for the high heterogeneity of PCOS expressions. With this funding, they seek to reshape the way PCOS healthcare is delivered.

Company Information

Company

Solence

Location

Paris, Ile De France, France

About

Solence is a women's health startup founded in 2022 by Clara Stephenson, aimed at rethinking the care of women suffering from Polycystic Ovary Syndrome (PCOS). The company focuses on personalized and patient-centric care through digital therapeutics and lifestyle-based interventions. Solence's mission is to increase the healthy life expectancy of women by providing tailored PCOS care utilizing data insights. Their first product is a patient app designed for symptom relief through lifestyle changes, underpinned by peer-reviewed research.

Solence raises €1.6M Seed funding to rethink PCOS care, aiming to provide personalised support for women with Polycystic Ovary Syndrome.

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Company Information